Varex Imaging (NASDAQ:VREX) Upgraded at Wall Street Zen

Varex Imaging (NASDAQ:VREX) was upgraded by stock analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a note issued to investors on Saturday.

Several other equities analysts have also recently issued reports on VREX. B. Riley Financial restated a “buy” rating on shares of Varex Imaging in a research note on Thursday, February 12th. Oppenheimer dropped their target price on shares of Varex Imaging from $23.00 to $18.00 and set an “outperform” rating on the stock in a report on Wednesday, November 19th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $14.50 price target on shares of Varex Imaging in a report on Monday, February 2nd. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Varex Imaging in a research note on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $16.17.

Varex Imaging Stock Performance

Shares of Varex Imaging stock opened at $13.17 on Friday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.87 and a current ratio of 3.89. Varex Imaging has a 1 year low of $6.76 and a 1 year high of $14.56. The firm’s 50-day simple moving average is $13.30 and its 200-day simple moving average is $12.21. The firm has a market cap of $551.82 million, a PE ratio of -8.03 and a beta of 0.90.

Varex Imaging (NASDAQ:VREX) last announced its quarterly earnings data on Tuesday, February 10th. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.05. The firm had revenue of $209.60 million during the quarter, compared to analyst estimates of $207.83 million. Varex Imaging had a positive return on equity of 8.43% and a negative net margin of 7.92%.Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. Equities analysts forecast that Varex Imaging will post 0.53 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Empowered Funds LLC raised its holdings in shares of Varex Imaging by 7.3% during the first quarter. Empowered Funds LLC now owns 179,128 shares of the company’s stock valued at $2,078,000 after buying an additional 12,151 shares during the last quarter. Jane Street Group LLC increased its position in Varex Imaging by 17.9% in the 1st quarter. Jane Street Group LLC now owns 159,362 shares of the company’s stock valued at $1,849,000 after acquiring an additional 24,160 shares during the period. Cooke & Bieler LP increased its position in Varex Imaging by 0.7% in the 2nd quarter. Cooke & Bieler LP now owns 2,136,843 shares of the company’s stock valued at $18,526,000 after acquiring an additional 14,160 shares during the period. Savant Capital LLC bought a new stake in Varex Imaging during the 2nd quarter valued at $154,000. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its position in Varex Imaging by 228.7% during the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 102,380 shares of the company’s stock worth $888,000 after acquiring an additional 71,237 shares during the period.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.